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التهاب الثدي احلبييب
خطط التشخيص و التطبيقات العالجية للمرضى العمانيني
عادل اجلراح ، فارنا تارانيكانتي، ريتو لكتاكيا، ا�شماء اجلابري، �شكبال �شوهني
امللخ�ص: الهدف: يعترب اإلتهاب الثدي احلبيبي مر�ض حميد ونادر ي�شيب الثدي لأ�شباب جمهوله، وعادة ما يتم ت�شخي�شه ب�شكل خاطىء 
�رسيريا واإ�شعاعيا على اأنه ورم خبيث يف الثدي، ونتيجة لذلك قد تتم معاجلته ب�شكل خاطىء. وعلى الرغم من عدم وجود طريقة ثابته 
اأو العالج الكيمياوي. وقد ظهرت  اأو )كورتيكو�شتريويد(  اأو باإ�شتخدام  لعالج هذا املر�ض املزمن، اإل انه قد متت جتربة العالج باجلراحة 
نتائج مثرية للجدل يف اأغلب الدرا�شات. الطريقة:  قد قامت وحدة اأمرا�ض الثدي مب�شت�شفي جامعة ال�شلطان قابو�ض بعمل درا�شة �رسيريه 
اأنه  اأن املر�ض خبيث، وقد مت ت�شخي�شه على  ال�رسيرية والإ�شعاعية  الفحو�شات  اأثبتت  الثدي حيث  �شملت ع�رسون مري�شة م�شابة بورم 
اإلتهاب ثدي حبيبي فقط من خالل الت�رسيح الن�شيجي. يف هذه الدرا�شة �شنناق�ض البيانات ال�رسيرية، والت�شخي�ض ومتابعة حالة املر�ض، 
و فر�ض عودة املر�ض وبيانات املتابعة للمري�شات مع مراجعة املراجع العلمية ذات ال�شلة بهذا املو�شوع. النتائج: اإن غالبية احلالت 
ملر�شانا هي حالت فردية لأ�شباب غري معروفة وقد ظهرت على �شكل كتلة يف اأحدى الثديني. وقد ظهر لبع�ض  املري�شات كتلة يف الثدي 
مع خراج ي�شاحبه ت�شخم يف العقد اللمفاوية. لقد ثبت  اإ�شعاعيا اإ�شابة اأربع من املري�شات بورم خبيث. اأر�شل ال�شديد للزراعة. وكانت 
النتيجة عدم وجود بكترييا. وقد اأظهر الفح�ض املجهري ال�شفات املميزة للتهاب الثدي احلبيبي. وقد خ�شعت جميع املري�شات للعالج 
جميع  اأظهرت  وقد  �شهرا(.   33-11( �شهرا   15 ملدة  املري�شات  متابعة  متو�شط  كان  و  اأ�شابيع  �شتة  ملدة  احليوية  امل�شادات  با�شتخدام 
املري�شات تقل�ض تام مع عدم ظهور جديد للمر�ض. وقد اأظهرت واحدة من املري�شات رجوع للمر�ض ولكنها ا�شتجابت للعالج مبزيد من 
امل�شاد احليوي. اخلال�شة: اأن هذه الدرا�شة املو�شعة واملفردة على حالت اإلتهاب الثدي احلبيبي يف عمان قد �شلطت ال�شوء على الأخطاء يف 
ت�شخي�ض هذا النوع غري الورمي وغري معروف الأ�شباب . وقد اأكدت الدرا�شة على الإ�شتجابة املمتازة للعالج بامل�شادات احليوية لإلتهاب 
الثدي احلبيبي الذي طاملا اأعترب مر�شا ي�شعب عالجه ومثارا للجدل.
مفتاح الكلمات: التهاب الثدي احلبيبي؛ الت�رسيح الن�شيجي؛ املناعة الكيميائية؛ اأ�شعة الثدي؛ الأ�شعة التلفزيونية؛ الت�شخي�ض؛ م�شادات حيوية.
abstract: Objectives: Idiopathic granulomatous mastitis (IGM) is a rare benign disorder of the breast whose 
aetiology is controversial, and is often misdiagnosed clinically and radiologically as mammary malignancy; 
as a result, it may be incorrectly treated. Although no standard treatment is available for this chronic disease, 
surgery with or without corticosteroids has been tried with controversial results. This study discusses the clinical 
presentation, diagnosis, management, recurrence, and follow-up data of IGM with a review of relevant literature. 
Methods: From 2009–2012, the Breast Unit at Sultan Qaboos University Hospital, Oman, conducted a clinical 
study on 20 patients with breast lumps. Their clinical and radiological examinations were indeterminate, and a 
diagnosis of granulomatous mastitis was established only by histopathology. Results: The majority of the patients 
were cases of unknown aetiology, who presented with a unilateral breast mass. A few patients had a mass with an 
abscess, along with axillary lymphadenopathy. A total of 4 patients were suspected of malignancy using radiology. 
In all patients, sterilised pus was sent for culture and sensitivity. Microscopy showed the characteristic pattern of 
granulomatous inflammation. All patients were treated with antibiotics for 6 weeks, and the mean follow-up period 
was 15 months (11–33 months). All patients had complete remission with no further recurrence. Conclusion: 
This single largest study of cases of IGM in Oman highlights the pitfalls in diagnosing this non-neoplastic disease 
of unknown aetiology and uncertain pathogenesis. It emphasises IGM’s excellent response to antibiotics, which is 
crucial, as IGM is a disease which is notoriously difficult and controversial to treat.
Keywords: Breast; Granulomatous Mastitis; Pathology; Immunohistochemistry; Mammography; Ultrasonography; 
Diagnosis; Antibiotics; Oman.
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- Idiopathic granulomatous mastitis can mimic a breast carcinoma; it is hence vital, when treating patients, not to ignore the clinical, 
radiological and histopathological findings of this rare, though benign, challenging disease.
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Idiopathic granulomatous mastitis (IGM) is a rare benign disorder of the breast first described in 1972 by Kessler and Wolloch.1 
Most patients are women of childbearing age 
with a recent history of pregnancy and lactation.2 
Patients present with a unilateral painful breast 
lump, with no predilection to a particular quadrant. 
In most cases, there is no axillary lymph node 
involvement. Although the exact aetiology of IGM 
remains unclear, associations with autoimmune 
disorders, oral contraceptive use, pregnancy, 
hyperprolactinaemia and alpha-1 antitrypsin 
deficiency have been suggested.3 Diagnosis of IGM is 
also very challenging as the clinical and radiological 
features often mimic a carcinoma.4 The definitive 
diagnosis is usually established by histopathology. 
Although there is no clear clinical consensus 
regarding the ideal therapeutic management of 
IGM, wide local excision and corticosteroids are 
commonly used to treat this condition, albeit with 
a very high local recurrence rate.5 This article 
discusses the clinical presentation, diagnosis and 
management of 20 cases of IGM at Sultan Qaboos 
University Hospital (SQUH), a secondary care 
teaching hospital in Oman.
Methods
A prospective study was undertaken of 20 patients 
diagnosed with IGM and treated in SQUH from 
2009 to 2012. Female patients of all ages presenting 
with clinical features of breast lumps, with or 
without primary breast abscesses, were included in 
the study.  The diagnosis of IGM was based on core 
biopsy using a Bard® disposable 14 gauge core biopsy 
needle (Bard Biopsy Systems, Tempe, Arizona, USA). 
The biopsy was sent for immunohistochemistry, for 
pancytokeratin and epithelial cadherin (E-cadherin) 
staining, and the pus was sent for microscopy, 
culture and antibiotic sensitivity. All patients 
diagnosed with IGM were managed conservatively 
with systemic antibiotics consisting of augmentin 
(1 gm twice a day) for 6 weeks and metronidazole 
(400 mg three times a day) for two weeks. Patients 
who developed secondary breast abscesses had fine 
needle aspiration (FNAC) and a further course of 
antibiotics for another two weeks. Patients with 
previous surgery or medical treatment for chronic 
diseases, chronic mastitis, non-granulomatous 
mastitis, immunocompromised patients, and 
those allergic to the penicillin group of drugs were 
excluded from the study. Ethical clearance was 
obtained from the SQUH ethics committee. The 
data were entered into a predesigned proforma 
with the following variables: clinical presentation, 
radiological imaging, microbiological findings, 
histopathological assessment, treatment modalities, 
recurrence, and follow-up. The data were analysed 
using descriptive statistics.
Results
This study reports 20 patients who presented 
with a breast lump at the Breast Unit of Sultan 
Qaboos University Hospital (SQUH); all patients 
underwent triple assessment (clinical, radiological 
and histopathological) to establish the diagnosis of 
GM.
The clinical characteristics of the cases were 
as follows: 20 patients presented with a breast 
lump, ranging from 2−10 cm (mean size 5.6 cm), 
and manifesting as firm, tender, ill-defined and 
indurated. The lesions were unilateral. The right 
breast was affected in 12 cases (60%) and the left 
breast in 8 cases (40%), with most of the lumps 
centrally located around the areola. Only one 
patient developed a lump in the contralateral breast 
5 months after treatment, and the biopsy from the 
lump was suggestive of GM. Three of the patients 
(15%) presented with primary breast abscesses 
and 6 patients (30%) presented with secondary 
abscesses. A total of 13 of our patients (65%) had 
axillary lymphadenopathy, where the lymph nodes 
were firm and fixed with a mean size of 1.8 cm. 
Two patients (10%) had nipple retraction, two 
patients (10%) presented with nipple discharge 
- The use of broad-spectrum antibiotics may provide gratifying results in selected groups of patients, thus obviating the need for surgery 
and immunosuppressive drugs.
Application to patient care
- This study shows that conservative management of idiopathic granulomatous mastitis can prevent needless surgeries and the use of 
immunosuppressive agents, thereby decreasing morbidity. 
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and one patient presented with peau d’orange, a 
pitted or dimpled appearance of the skin which is 
characteristic of some types of breast cancer. The 
majority of our patients were of childbearing age 
(25–54 years), with a mean age of 37.5 years, and all 
of them were multiparous (mean = 4 children) and 
had breastfed their children. Two of them (10%) had 
a history of taking hormonal contraceptives [Table 
1]. 
The radiological features of the cases were 
determined through ultrasound and mammography. 
An ultrasound was performed in all 20 cases, with 
both a mammogram and an ultrasound done in 
the 7 cases (35%) which showed dilated ducts 
with thick debris, or cystic lesions with debris, or 
severe inflammatory changes [Figure 1]. The lesions 
ranged from 1–7cm.  In 4 of the patients (20%), a 
hypoechoic mass was seen on the ultrasound. The 
majority of the masses under mammography did 
not show any calcification, spiculation or changes 
involving the skin or nipple. However, in one case 
some skin-thickening was seen in the region of the 
skin and areola, and the nipple was retracted. In 4 
patients (20%), radiological findings were suspicious 
of malignancy. Several patients were graded using 
the Breast Imaging Reporting and Data System (BI-
RADS); three patients were graded as BI-RADS V 
and one patient as BI-RADS IV.6 
The histological and cytological characteristics 
of the cases were determined by FNAC, which was 
suggestive of IGM in 5 patients (25%), and was 
inconclusive for the others. All patients underwent 
core biopsy regardless of FNAC-confirmed IGM. In 
one patient, core biopsy was inconclusive for IGM, 
so an open biopsy was done which, by cytology, was 
suggestive of IGM. The sensitivity of core biopsy 
was 95%. All other cases on histopathology showed 
Table 1: Clinicopathological characteristics of patients















Right breast lump 12 (60)
Left breast lump 8 (40)
Nipple retraction 2 (10)
Nipple discharge 2 (10)
Peau d’orange 1 (5)
Axillary lymph nodes 13 (65)
radiological imaging
BI-RAD IV 1 (5)
BI-RAD V 3 (15)
Microbiology 









<1 year 6 (30)
>1 year 14 (70)
BI-RADS = Breast Imaging Reporting and Data System; IGM = 
idiopathic granulomatous mastitis. 
Figure 1: Ultrasound showing an irregular mass with 
both solid and cystic components.
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moderate to severe lobule-centric non-caseating 
granulomatous inflammation, involving most of the 
lobules in a global fashion, with a sparing of the ducts 
and the absence of fat necrosis in all of the biopsies. 
The necrotising granulomas comprised collections 
of granulocytes (predominantly neutrophils), 
lymphocytes and plasma cells, palisaded by sheets 
of epithelioid cells and foreign body giant cells with 
intact acini, or acini showing destruction [Figure 2]. 
Pancytokeratin and E-cadherin staining confirmed 
the lobular localisation of the granulomas and the 
progressive destruction of the acini. In one case, 
the severely inflamed lobule showed ectatic acini 
containing necrotic inspissated material. Two of 
the cases were suggestive of duct ectasia with GM. 
None of the cases showed caseating granulomas 
suggestive of tuberculosis. Gram, periodic acid-
Schiff, Ziehl-Neelsen and Giemsa stains did not 
reveal any microorganisms (bacteria, mycobacteria, 
fungi and parasites). 
In the subsequent treatment and follow-up of 
the cases, there was significant improvement in 
17 out of 20 patients (85%) treated conservatively 
with antibiotics. Surgical treatment with wide 
local excision was performed in one patient 
where the diagnosis could not be confirmed either 
radiologically or by core biopsy. Two patients were 
lost to follow-up after the initial treatment. Post-
treatment response was monitored both clinically 
and radiologically with a breast ultrasound every 3 
months. A total of 6 patients had secondary abscess 
formation (initially presenting with a hard mass) 
within the first 3 months, and these patients had 
FNAC of the abscess and were given antibiotics for 
a further two weeks. After a mean follow-up at 15 
months (11−33 months), there was no recurrence 
in 18 out of the 20 patients and all of them are in 
complete remission to date.
Discussion
IGM is an uncommon clinical condition involving 
the breast. Though the exact aetiology of this 
condition is not known, an autoimmune reaction 
to the protein secretions from the mammary ducts 
is implicated in its causation.7 Histologically, IGM 
is characterised by the presence of non-necrotic 
granulomas confined to breast lobules. As the 
radiological and clinical features closely mimic a 
carcinoma in most instances, IGM often poses 
a diagnostic and therapeutic dilemma. IGM has 
been reported to occur commonly in women of 
reproductive age,8 and this has been seen in our 
study, wherein the mean age of the patients was 
37.4 years. Typically, IGM presents as a breast mass; 
pain, skin-thickening, abscess formation, sinus 
or regional lymphadenopathy may be associated 
features.8
Thus, when women with IGM present with a 
hard unilateral mass, axillary lymphadenopathy, 
nipple retraction or peau d’orange, IGM can be 
mistaken for a carcinoma.5 In our study, all of the 
patients presented with a unilateral mass, which 
was most often situated in the periphery of the 
breast. Only one patient developed a de novo mass 
in the contralateral breast a few months after the 
diagnosis of IGM in the other breast. However, the 
de novo mass was suggestive of IGM when using 
core biopsy. Similar to other studies, our patients 
also commonly presented with cellulitis, axillary 
lymphadenopathy, abscesses, skin-thickening and 
nipple retraction. Mammographic features of IGM 
are essentially nonspecific, with focal asymmetric 
density being the most common feature.7–11
Our study showed that the most common 
radiological findings observed were dilated ducts 
with inflammatory changes, with some patients 
(15%) showing cystic lesions with thick debris. 
Using mammography, 20% of our patients displayed 
asymmetric diffuse density of fibroglandular tissue 
and with ultrasound, 20% of the patients showed 
hypoechoic ill-defined lesions. 
Figure 2: Breast lobule under haematoxylin and 
eosin stain and x 100 magnification, showing  
expansion due to a granulomatous inflammation. 
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With these nonspecific clinical and radiological 
findings, histopathology played a crucial role in 
diagnosing the cases of granulomatous lobular 
mastitis. FNAC for pus aspiration and culture was 
done in 6 patients (30%) who presented with an 
abscess, because IGM can mimic an abscess, and 
FNAC gives faster results than core biopsy. In our 
study, core biopsy was more accurate than FNAC 
in diagnosing IGM, as the characteristic features of 
IGM were more obvious with histopathology. As 
in the study done by Larsen et al., core biopsy was 
more accurate as it showed the tissue architecture.8 
Core biopsy was diagnostic in 19 patients (95%), 
and was indeterminate in only one patient.
Granulomatous lobular mastitis is characterised 
histologically by the presence of non-necrotising 
granulomas, usually admixed with neutrophils 
originating in the breast lobules.8 The other 
conditions that can mimic IGM are mammary duct 
ectasia and chronic inflammatory conditions like 
plasma cell mastitis, tuberculosis, histoplasmosis, 
sarcoidosis and Wegener’s granuloma.11 
Hence, a biopsy is useful to distinguish IGM 
from other granulomatous conditions, as 
well as establishing malignancy. In our study, 
the cases were characterised by chronic 
lobulitis with granulomatous inflammation. The 
granulomas comprised collections of granulocytes 
(predominantly polymorphs), palisaded by sheets 
of epithelioid cells and foreign body giant cells. 
Pancytokeratin and E-cadherin staining confirmed 
the lobular localisation of the granulomas and the 
progressive destruction of the acini. 
The exact causes of IGM are still unknown. 
Keller and Wolloch proposed an autoimmune 
pathogenesis.1 It has been postulated that as 
most women presenting with IGM are in the 
reproductive age group, and since many patients 
had previously given birth or were lactating at the 
time of the initial symptoms, a localised immune 
response to extravasated secretions from lobules 
may occur.  Miliauskas et al. reported a case in 
which they showed that immunohistochemical 
staining of the lesion contained predominantly 
stromal T lymphocytes.12 This might be due to a 
local cellular response to injury as there has been 
no evidence of systemic immune abnormalities 
such as the formation of autoantibodies or antigen-
antibody complexes. 
Furthermore, in our study, no microorganisms 
(bacteria, mycobacteria, fungi and parasites) were 
demonstrated by Gram, periodic acid-Schiff, Ziehl-
Neelsen or Giemsa stains. Going et al. emphasised 
the importance of use of appropriate swabs and 
appropriate transport media to recover these 
organisms.13 Miles et al. reported that immediate 
inoculation into Robertson's cooked meat broth has 
been shown to increase the recovery and range of 
organisms from wound swabs.14
The treatment of IGM remains contentious, and 
there is no clear clinical consensus regarding the 
ideal therapeutic management of IGM. Although 
several studies have reported different approaches 
for the management of IGM, many of these 
treatment algorithms were formulated without a 
definitive initial diagnosis.15 The treatment plan 
for IGM followed at most centres is to perform 
a complete resection or an open biopsy with 
corticosteroid therapy.16 However, surgery can 
be complicated by abscess formation, fistulas, 
scarring and chronic suppuration. Chronic mastitis 
after excisional biopsies has also been reported.17 
Imoto et al. followed 29 patients with IGM, of 
which 11 (38%) showed relapse, and thus patients 
must be followed carefully after treatment by 
excision.18 Bani-Hani et al. reported 24 patients 
with histologically-confirmed IGM who were 
treated by wide local excision. Their analysis of 
patients over a period of 8 years showed a 16% 
recurrence after a mean follow-up period of 31.2 
months.11 As some studies have implicated an 
immune aetiology for IGM, many centres have 
used prednisolone as a common regimen especially 
with clinically advanced diseases or more severe 
symptoms. However, high-dose steroids, in 
addition to their potential side effects, have been 
linked with a recurrence rate as high as 50%, as seen 
in one study by Azlina et al.19 Immunosuppressive 
agents, like methotrexate or azathioprine, have 
also been utilised, with variable responses, in cases 
refractory to the above therapies.20–21 Akbulut et 
al. retrospectively analysed 541 IGM cases treated 
with steroids and/or methotrexate between 1972 
and 2010. They found a high recurrence rate in 
patients using steroids, and also the occurrence of 
adverse side effects such as steroid-induced diabetes 
mellitus. However, in 4 cases exhibiting recurrence, 
when methotrexate was used instead of steroids, 
it was found to be more effective in preventing 
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complications, resolving the inflammatory process, 
and limiting the side effects of corticosteroids.22
Conservative management has been tried by 
various centres due to the variable responses to 
different therapeutic strategies. In a study by Lai et 
al., 8 patients were treated conservatively, with no 
surgery performed or medication given, and were 
monitored with close regular surveillance. A total 
of 50% of the patients had spontaneous complete 
resolution of disease after a mean interval of 14.5 
months.23 Based on the clinical presentation of the 
cases and the presence of acute inflammatory cells, 
the Breast Unit at SQUH developed a diagnostic 
and treatment algorithm by conservatively 
managing histopathologically proven cases of IGM 
[Figure 3]. With this mode of management, all 
women with IGM showed improvement, excluding 
the two patients who were lost to follow-up.
Based on the results of our study, the Breast 
Unit team at SQUH implemented the following 
treatment plan for women diagnosed with 
granulomatous lobular mastitis. Initially, a course 
of antibiotics is prescribed for 6 weeks, with 
assessment of the patient every 3 months. If there is 
recurrence, a second course of antibiotics is given. 
If treatment fails, or if minimal or no improvement 
is seen after the second course of antibiotics, other 
options are considered. At SQUH, patients are 
examined by the breast surgeon at least every two 
weeks for the first month, then on a monthly basis 
for the next 3 months. A follow-up ultrasound 
is performed 6 months after the symptoms have 
resolved. Thereafter, if the patient is asymptomatic, 
and imaging does not show any recurrence, the 
patient is advised to undergo annual screening 
following the national screening guidelines.24
Conclusion
IGM is an enigma because of its nonspecific 
clinical and radiological characteristics, and poses a 
diagnostic and therapeutic dilemma to the treating 
surgeon. Nevertheless, the ultimate diagnosis of this 
chronic inflammatory disease rests on core biopsy. 
In our series, treatment with antibiotics produced 
excellent responses and patients did not require 
any other forms of treatment. As the course of the 
disease is unpredictable with a strong tendency 
towards persistence and recurrence, a conservative 
approach seems to be the best option in the 
management of this disease. Greater awareness 
of the rare entity of IGM is mandatory to avoid 
unnecessary mastectomies and to reduce morbidity 
among patients. 
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